Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease (2004)

  • Authors:
  • USP affiliated authors: MARANHAO, RAUL CAVALCANTE - FCF ; BYDLOWSKI, SERGIO PAULO - FM
  • USP Schools: FCF; FM
  • DOI: 10.1007/bf02665353
  • Subjects: EMULSÕES (FORMAS FARMACÊUTICAS); MIELOMA MÚLTIPLO; QUIMIOTERAPIA; LIPOPROTEÍNAS LDL
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1007/bf02665353 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Cancer Chemotherapy and Pharmacology

    ISSN: 0344-5704

    Citescore - 2017: 2.91

    SJR - 2017: 1.147

    SNIP - 2017: 0.899


  • How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      HUNGRIA, Vania Tietsche de Moraes; LATRILHA, Maria C.; RODRIGUES, Debora G.; et al. Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease. Cancer Chemotherapy and Pharmacology, Berlim, v. 53, n. 1, p. 51-60, 2004. DOI: 10.1007/bf02665353.
    • APA

      Hungria, V. T. de M., Latrilha, M. C., Rodrigues, D. G., Bydlowski, S. P., Chiattone, C. S., & Maranhão, R. C. (2004). Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease. Cancer Chemotherapy and Pharmacology, 53( 1), 51-60. doi:10.1007/bf02665353
    • NLM

      Hungria VT de M, Latrilha MC, Rodrigues DG, Bydlowski SP, Chiattone CS, Maranhão RC. Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease. Cancer Chemotherapy and Pharmacology. 2004 ; 53( 1): 51-60.
    • Vancouver

      Hungria VT de M, Latrilha MC, Rodrigues DG, Bydlowski SP, Chiattone CS, Maranhão RC. Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease. Cancer Chemotherapy and Pharmacology. 2004 ; 53( 1): 51-60.

    Referências citadas na obra
    Ades A, Carvalho JP, Graziani, SR, Amancio RF, Souen JS, Pinotti JA, Maranhão RC (2001) Uptake of a cholesterol-rich emulsion by neoplastic ovarian tissues. Gynecol Oncol 82:84
    Attal M, Harousseau JL, Stoppa AM (1996) A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med 335:91
    Barlogie B, Smith L, Alexanian R (1984) Effective treatment of advanced multiple myeloma resistant to alkylating agents. N Engl J Med 310:1353
    Bernardes-Silva H, Toffoletto O, Bortolotto LA, Latrilha MCM, Krieger EM, Pileggi F, Maranhão RC (1995) Malignant hypertension is accompanied by marked alterations in chylomicron metabolism. Hypertension 26:1207
    Borba EF, Bonfa E, Vinagre CGC, Ramires JAF, Maranhão RC (2000) Chylomicron metabolism is markedly altered in systemic lupus erythematosus. Arthritis Rheum 43:1033
    Brown MS, Goldstein JL (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232:34
    Brown MS, Dana SE, Goldstein JL (1974) Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured human fibroblasts. J Biol Chem 249:789
    Desikan R, Barlogie B, Sawyer J (2000) Results of high dose therapy for 1,000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities. Blood 95:4008
    Durie BGM, Salmon SE (1975) A clinical staging system for multiple myeloma. Cancer 36:842
    Fine JM, Fine A, Burstein M (1982) Decreased concentration of low density lipoproteins in malignant forms of monoclonal gammopathy. Rev Fr Transfus Immunohematol 25:273
    Friedewald WT, Levy RI, Fredrickson DD (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499
    Gal D, Ohashi M, MacDonald PC, Buchsbaum HJ, Simpson ER (1981) Low-density lipoprotein as a potential vehicle for chemotherapeutic agents and radionucleotides in the management of gynecologic neoplasms. Am J Obstet Gynecol 139:877
    Ginsburg GS, Small DM, Atkinson D (1982) Microemulsions of phospholipids and cholesterol esters. J Biol Chem, 257:8216
    Ginsberg H, Gilbert HS, Gibson JC, Ngoc-Anh L, Virgil BW (1986) Increased low-density-lipoprotein catabolism in myeloproliferative disorders. Ann Intern Med 96:311
    Graziani SR, Igreja FAF, Hegg R, Meneghetti C, Brandizzi LI, Barboza R, Amancio RF, Pinotti JA, Maranhão RC (2002) Uptake of a cholesterol-rich emulsion by breast cancer. Gynecol Oncol 85:493
    Grundy SM, Vega GL, Bilheimer DW (1985) Kinetic mechanisms determine variability in low density lipoprotein levels and rise with age. Arteriosclerosis 5:623
    Gueddari N, Favre G, Hachem H, Marek E, Le Gaillard F, Soula G (1993) Evidence for up-regulated low density lipoprotein receptor in human lung adenocarcinoma cell line A549. Biochemie 75:811
    Hachem H, Favre G, Ghalim N, Puchois P, Fruchart JC, Soula G (1987) Quantitative abnormalities of lipoprotein particles in multiple myeloma. J Clin Chem Clin Biochem 25:675
    Harousseau JL, Attal M, Divine M (1995) Autologous stem cell transplantation after first remission induction treatment in multiple myeloma. A report of the French registry on autologous transplantation in multiple myeloma. Blood 85:3077
    Henriksson P, Ericsson S, Stege R, Ericsson M, Rudling M, Berglund L, Angelin B (1989) Hypocholesterolaemia and increased elimination of low-density lipoproteins in metastatic cancer of the prostate. Lancet 2:1178
    Hirata RDC, Hirata MH, Mesquita CH, Cesar TB, Maranhão RC (1999) Effects of apolipoprotein B-100 on the metabolism of a lipid microemulsion model in rats. Biochim Biophys Acta 1437:53
    Lo YK, Smith GL, Brown MS, Goldstein JL (1978) Low-density lipoprotein (LDL) receptor activity in human acute myelogenous leukemia cells. Blood 52:1099
    Hungria VTM, Brandizzi LI, Chiattone, Bydlowski SP, Maranhão RC (1999) Metabolism of an artificial emulsion resembling chylomicrons in patients with multiple myeloma. Leuk Res 23:637
    Innerarity TL, Mahley RW (1978) Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins. Biochemistry 17: 1440
    Leppälä J, Kallio M, Nikula, T, Nikkinen P, Liewendahl K, Jääskeläinen J, Savolainen S, Gylling H, Hiltunen J, Callaway J, Kahl S, Färkkilä M (1995) Accumulation of99mTc-low-density lipoprotein in human malignant glioma. Br J Cancer 71:383
    Levin VA, Hoffman W, Weinkam RJ (1978) Pharmacokinetics of BCNU in man: a preliminary study of 20 patients. Cancer Treat Rep 62:1305
    Levy Y, Spira G, Brook GJ, Aviram M, Tatarsky I, Carter A (1984) Plasma cholesterol concentration and extra lipid band in monoclonal gammopathies. Postgrad Med J 60:449
    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1958) Protein measurement with the folin phenol reagent. J Biol Chem 193:265
    Maranhão RC, Garicochea B, Silva EL, Llacer PD, Pileggi FJC, Chamone DAF (1992) Increased plasma removal of microemulsions resembling the lipid phase of low-density lipoproteins (LDL) in patients with acute myeloid leukemia. Braz J Med Biol Res 25:1003
    Maranhão RC, Cesar TB, Pedroso-Mariani S, Hirata MH, Mesquita CH (1993) Metabolic behavior in rats of a non-protein microemulsion resembling LDL. Lipids 28:691
    Maranhão RC, Garicochea B, Silva EL, Llacer PD, Cadena SMS, Coelho IJC, Meneghetti JC, Pileggi FJC, Chamone DAF (1994) Plasma kinetics and biodistribution of a lipid emulsion resembling low-density lipoprotein in patients with acute leukemia. Cancer Res 54:4660
    Maranhão RC, Feres MC, Martins MT, Mesquita CH, Toffoletto O, Vinagre CGC, Gianini SD, Pileggi F (1996) Plasma kinetics of a chylomicron-like emulsion in patients with coronary artery disease. Atherosclerosis 126:15
    Maranhão RC, Roland IA, Toffoletto O, Ramires JA, Gonccalves P, Mesquita CH, Pileggi P (1997) Plasma kinetic behavior in hyperlipidemic subjects of a lipidic microemulsion that binds to LDL receptors. Lipids 32:627
    Maranhão RC, Graziani SR, Yamaguchi N, Melo RF, Latrilha MC, Rodrigues DG, Couto RD, Schreier S, Buzaid AC (2002) Association of carmustine with a lipid emulsion: in vitro, in vivo and preliminary studies in cancer patients. Cancer Chemother Pharmacol 49:487
    Matthews CME (1957) The theory of tracer experiments with 131I-labeled plasma proteins. Phys Med Biol 2:36
    Miller NE (1984) Why does plasma low density lipoprotein concentration in adults increase with age?. Lancet 1:263
    Oken MM, Harrington DP, Abramson N, Kyle RA, Knospe W, Glick JH (1997) Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma. Results of Eastern Cooperative Oncology Group Study E2479. Cancer 79:1561
    Pinto LB, Wajgarten M, Silva EL, Vinagre CGC, Maranhao RC (2001) Plasma kinetics of a cholesterol-rich emulsion in young, middle-aged and elderly subjects. Lipids 36:1307
    Santos RD, Sposito AC, Ventura LI, Cesar LAM, Ramires JAF, Maranhão RC (2000) Effect of pravastatin on plasma removal of a chylomicron-like emulsion in men with coronary artery disease. Am J Cardiol 85:1163
    Santos RD, Ventura LI, Sposito AC, Schreiber R, Ramires JAF, Maranhão RC (2001) The effects of gemfibrozil upon the metabolism of chylomicron-like emulsions in patients with endogenous hypertriglyceridemia. Cardiovasc Res 49:456
    Shoji T, Ishimura E, Inaba M, Tabata T, Nishizawa Y (2001) Atherogenic lipoproteins in end-stage renal disease. Am J Kidney Dis 38:S30
    Spósito AC, Maranhão RC, Vinagre CGC, Santos RD, Ramires JAF (2001) Effects of etofibrate upon the metabolism of chylomicron-like emulsions in patients with coronary artery disease. Atherosclerosis 154:455
    Ueyama Y, Matsuzawa U, Yamashita, S, Funahashi T, Sakai N, Nakamura T, Kubo M, Tarui S (1990) Hypocholesterolemic factor from gallbladder cancer cells. Lancet 336:707
    Vinagre CG, Stolf NAG, Bocchi E, Maranhão RC (2000) Chylomicron metabolism in patients submitted to cardiac transplantation. Transplantation 69:532
    Vitols S, Angelin B, Ericsson S, Gahrton G, Juliusson G, Masquelier M, Paul C, Peterson C, Rudling M, Soderberg-Reid K, et al (1990) Uptake of low density lipoproteins by human leukemic cells in vivo: relation to plasma lipoprotein levels and possible relevance for selective chemotherapy. Proc Natl Acad Sci U S A 87:2598
    Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI: